BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...Inc. (NASDAQ:ILMN). Winter, who first used phage display technology to humanize antibodies, is chairman of Biosceptre International Ltd....
BioCentury | May 18, 2018
Finance

China comes to Europe

...Fund, Consort Medical plc, RMI Partners, Wondfo Biotech , Technology Venture Partners Diagnostics Infectious diseases Biosceptre International Ltd....
BioCentury | Aug 11, 2014
Clinical News

BIL-010t: Phase I data

...tolerated with mild to moderate localized skin reactions reported as the only side effect. Additionally, Biosceptre...
...BCC lesions during the course of treatment. Biosceptre could not be reached for next steps. Biosceptre International Ltd....
BioCentury | Jul 14, 2014
Financial News

Biosceptre International Ltd completes venture financing

Biosceptre International Ltd ., Cambridge, U.K. Business: Cancer Date completed: 2014-07-09 Type: Venture financing Raised: A$5 million ($4.7 million) Investors: Existing investors WIR Staff cancer...
BioCentury | Jul 21, 2008
Company News

Biosceptre board of directors update

Biosceptre International Ltd. , North Ryde, Australia Business: Cancer Appointed: Alan Bootes as chairman, formerly global manager at Pfizer Inc. WIR Staff...
BioCentury | Jan 8, 2007
Strategy

Beyond the land Down Under

...antibodies in preclinical development for colorectal cancer. The work will complement the company's collaboration with Biosceptre International Ltd....
BioCentury | Dec 11, 2006
Company News

Peptech, Scancell Ltd. deal

...colorectal cancer, and other undisclosed preclinical antibodies to treat cancer. Under a 2003 JV with Biosceptre...
BioCentury | Oct 5, 2005
Company News

Peptech names Chiplin CEO

...Dundee, U.K.). PTD is developing a diagnostic test for prostate cancer through a JV with Biosceptre...
BioCentury | Aug 29, 2005
Clinical News

Prostate cancer test diagnostic data

...antibody detection method through a joint venture with Biosceptre. Peptech Ltd. (ASX:PTD), North Ryde, Australia Biosceptre International Ltd....
BioCentury | Jul 25, 2005
Company News

Domantis, Biosceptre International, Peptech deal

...and in vivo diagnostic products against an oncology target from a JV between PTD and Biosceptre...
...Domantis will receive annual fees, research funding and revenue sharing. Domantis Ltd. , Cambridge, U.K. Biosceptre...
Items per page:
1 - 10 of 10
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...Inc. (NASDAQ:ILMN). Winter, who first used phage display technology to humanize antibodies, is chairman of Biosceptre International Ltd....
BioCentury | May 18, 2018
Finance

China comes to Europe

...Fund, Consort Medical plc, RMI Partners, Wondfo Biotech , Technology Venture Partners Diagnostics Infectious diseases Biosceptre International Ltd....
BioCentury | Aug 11, 2014
Clinical News

BIL-010t: Phase I data

...tolerated with mild to moderate localized skin reactions reported as the only side effect. Additionally, Biosceptre...
...BCC lesions during the course of treatment. Biosceptre could not be reached for next steps. Biosceptre International Ltd....
BioCentury | Jul 14, 2014
Financial News

Biosceptre International Ltd completes venture financing

Biosceptre International Ltd ., Cambridge, U.K. Business: Cancer Date completed: 2014-07-09 Type: Venture financing Raised: A$5 million ($4.7 million) Investors: Existing investors WIR Staff cancer...
BioCentury | Jul 21, 2008
Company News

Biosceptre board of directors update

Biosceptre International Ltd. , North Ryde, Australia Business: Cancer Appointed: Alan Bootes as chairman, formerly global manager at Pfizer Inc. WIR Staff...
BioCentury | Jan 8, 2007
Strategy

Beyond the land Down Under

...antibodies in preclinical development for colorectal cancer. The work will complement the company's collaboration with Biosceptre International Ltd....
BioCentury | Dec 11, 2006
Company News

Peptech, Scancell Ltd. deal

...colorectal cancer, and other undisclosed preclinical antibodies to treat cancer. Under a 2003 JV with Biosceptre...
BioCentury | Oct 5, 2005
Company News

Peptech names Chiplin CEO

...Dundee, U.K.). PTD is developing a diagnostic test for prostate cancer through a JV with Biosceptre...
BioCentury | Aug 29, 2005
Clinical News

Prostate cancer test diagnostic data

...antibody detection method through a joint venture with Biosceptre. Peptech Ltd. (ASX:PTD), North Ryde, Australia Biosceptre International Ltd....
BioCentury | Jul 25, 2005
Company News

Domantis, Biosceptre International, Peptech deal

...and in vivo diagnostic products against an oncology target from a JV between PTD and Biosceptre...
...Domantis will receive annual fees, research funding and revenue sharing. Domantis Ltd. , Cambridge, U.K. Biosceptre...
Items per page:
1 - 10 of 10